Skip to menu Skip to content Skip to footer

2012

Journal Article

Nanopatch targeted delivery of both antigen and adjuvant to skin synergistically drives enhanced antibody responses

Fernando, Germain J. P., Chen, Xianfeng, Primero, Clare A., Yukiko, Sally R., Fairmaid, Emily J., Corbett, Holly J., Frazer, Ian H., Brown, Lorena E. and Kendall, Mark A. F. (2012). Nanopatch targeted delivery of both antigen and adjuvant to skin synergistically drives enhanced antibody responses. Journal of Controlled Release, 159 (2), 215-221. doi: 10.1016/j.jconrel.2012.01.030

Nanopatch targeted delivery of both antigen and adjuvant to skin synergistically drives enhanced antibody responses

2012

Journal Article

Rapid kinetics to peak serum antibodies is achieved following influenza vaccination by dry-coated densely packed microprojections to skin

Chen, Xianfeng, Fernando, Germain J. P., Raphael, Anthony P., Yukiko, Sally R., Fairmaid, Emily J., Primiero, Clare A., Frazer, Ian H., Brown, Lorena E. and Kendall, Mark A. F. (2012). Rapid kinetics to peak serum antibodies is achieved following influenza vaccination by dry-coated densely packed microprojections to skin. Journal of Controlled Release, 158 (1), 78-84. doi: 10.1016/j.jconrel.2011.10.026

Rapid kinetics to peak serum antibodies is achieved following influenza vaccination by dry-coated densely packed microprojections to skin

2011

Journal Article

Improving the reach of vaccines to low-resource regions, with a needle-free vaccine delivery device and long-term thermostabilization

Chen, Xianfeng, Fernando, Germain J. P., Crichton, Michael L., Flaim, Christopher, Yukiko, Sally R., Fairmaid, Emily J., Corbett, Holly J., Primiero, Clare A., Ansaldo, Alexander B., Frazer, Ian H., Brown, Lorena E. and Kendall, Mark A. F. (2011). Improving the reach of vaccines to low-resource regions, with a needle-free vaccine delivery device and long-term thermostabilization. Journal of Controlled Release, 152 (3), 349-355. doi: 10.1016/j.jconrel.2011.02.026

Improving the reach of vaccines to low-resource regions, with a needle-free vaccine delivery device and long-term thermostabilization